FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
We have now added a new section called the "Assay History List" to the "At A Gla...